Literature DB >> 18577936

[The clinical-genealogic and molecular-genetic characteristics of oculopharyngeal muscular dystrophy in the Republic of Sakha (Yakutia)].

N R Maksimova, I A Nikolaeva, M N Korotkov, T Ikeuchi, O Onodera, M Nishizava, S K Stepanova, Kh A Kurtanov, A L Sukhomiasova, A N Nogovitsyna, E E Gurinova, V A Stepanov, V P Puzyrev.   

Abstract

The clinical-genealogic and molecular-genetic investigation of oculopharyngeal muscular dystrophy (OPMD) in the Republic of Sakha (Yakutia) was performed. It was investigated 33 unrelated Yakut families with 38 patients and 2 russian families with 2 patients and 59 their healthy relatives as well. The high clinical polymorphism of disease was found in patients with OPMD. The mutation in exon 1 of the PABPN1 gene resulting in the expansion of GCG-repeats up to 10 is revealed. Using direct sequencing of the PABPN1 gene in 17 families (16 Yakut, 1 Russian), we identified a type of this mutation as an insertion of 4 GCG-repeats. Frequency of OPMD in the Yakut population is 1:11 680 that is 10-20 times higher comparing to european populations. This is a first report on the patients with OPMD from the Republic of Sakha with diagnosis confirmed by molecular-genetic analysis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18577936

Source DB:  PubMed          Journal:  Zh Nevrol Psikhiatr Im S S Korsakova        ISSN: 1997-7298


  3 in total

1.  Genomes, populations and diseases: ethnic genomics and personalized medicine.

Authors:  V A Stepanov
Journal:  Acta Naturae       Date:  2010-10       Impact factor: 1.845

2.  The lysosomal disease caused by mutant VPS33A.

Authors:  Elena V Pavlova; Aleksey Shatunov; Lena Wartosch; Alena I Moskvina; Lena E Nikolaeva; Nicholas A Bright; Karen L Tylee; Heather J Church; Andrea Ballabio; J Paul Luzio; Timothy M Cox
Journal:  Hum Mol Genet       Date:  2019-08-01       Impact factor: 6.150

Review 3.  Mucopolysaccharidosis-Plus Syndrome.

Authors:  Filipp Vasilev; Aitalina Sukhomyasova; Takanobu Otomo
Journal:  Int J Mol Sci       Date:  2020-01-09       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.